This rationale stems from a study suggesting that MOR-induced ß-arrestin 2 dependent signaling is responsible for opioid respiratory depression, whereas adenylyl cyclase inhibition produces analgesia. This evidence concerns the gene ARRB1 and Respiratory insufficiency due to muscle weakness.